AG
Insider
Alastair Garfield
Chief Scientific OfficerAlastair Garfield (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $817K of RYTM (6,963 sh across 3 lots, as filed), executed Aug 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$817K
shares × price, as filed
Last traded
Aug 13
Filed Aug 17
Median ADV $88.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $817K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
RYTM
Rhythm Pharmaceuticals, Inc.
RYTM · 0 buys · 1 sell
1 filing
Recent filings
RYTMSALE
Rhythm Pharmaceuticals, Inc.
View filing →
$817K6,963 sh across 3 lots
Exec Aug 13
Filed Aug 17 · 5:57 PM ET